Phathom Pharmaceuticals shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Phathom Pharmaceuticals (PHAT) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Phathom Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Phathom Pharmaceuticals held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Phathom Pharmaceuticals by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $4.3M | 417k | 10.30 |
| 2024-03-31 | $2.2M | 207k | 10.62 |
| 2023-12-31 | $1.9M | 210k | 9.13 |
| 2023-09-30 | $1.4M | 139k | 10.37 |
| 2023-06-30 | $2.2M | 155k | 14.32 |
| 2023-03-31 | $348k | 49k | 7.14 |
| 2022-12-31 | $830k | 74k | 11.22 |
| 2022-06-30 | $441k | 52k | 8.42 |
| 2022-03-31 | $386k | 28k | 13.62 |
| 2021-12-31 | $671k | 34k | 19.67 |
| 2021-09-30 | $230k | 7.2k | 32.11 |
| 2020-12-31 | $1.5M | 44k | 33.21 |
| 2019-12-31 | $202k | 6.5k | 31.12 |